Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nyse  >  USANA Health Sciences, Inc.    USNA

Delayed Quote. Delayed  - 07/29 10:02:01 pm
137.32 USD   +0.13%
07/27 USANA HEALTH SC : posts 2Q profit
07/26 USANA HEALTH SC : Reports Record Second Quarter Financial Results
07/19 USANA HEALTH SC : @TeamUSANA Steps Onto The World Stage As More Than..
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 

USANA Health Sciences, Inc. : USANA Schedules First Quarter Earnings Release and Conference Call

share with twitter share with LinkedIn share with facebook
share via e-mail
0
04/16/2012 | 10:50pm CEST

USANA Health Sciences, Inc. (NYSE:USNA) today announced that first quarter results will be released after the close of market Tuesday, April 24, 2012. USANA executives will hold a conference call to discuss this announcement with analysts and institutional investors the following morning at 11:00 a.m. Eastern Time.

The call will be broadcast over the Internet and can be accessed at http://www.usanahealthsciences.com.

The webcast is also being distributed over Thomson's Investor Distribution Network to both institutional and individual investors. Individual investors can listen to the call through Thomson's individual investor center at www.fulldisclosure.com or by visiting any of the investor sites in Thomson's Individual Investor Network. Institutional investors can access the call via Thomson's password-protected event management site, StreetEvents (www.streetevents.com).

About USANA

USANA develops and manufactures high-quality nutritional, personal care, and weight-management products that are sold directly to Associates and Preferred Customers throughout the United States, Canada, Australia, New Zealand, Hong Kong, Japan, Taiwan, South Korea, Singapore, Mexico, Malaysia, the Philippines, the Netherlands, the United Kingdom, Thailand, France and Belgium. Additionally, USANA's wholly owned subsidiary, BabyCare, Ltd., operates a direct selling business in China. More information on USANA can be found at http://www.usanahealthsciences.com.

USANA Health Sciences, Inc.
Patrique Richards, 801-954-7961
Investor Relations
investor.relations@us.usana.com


© Business Wire 2012
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on USANA HEALTH SCIENCES, INC
07/28 USANA HEALTH SCIENCES : @TeamUSANA Steps Onto The World Stage As More Than 70 At..
07/27 USANA HEALTH SCIENCES : posts 2Q profit
07/26 USANA HEALTH SCIENCES INC : Results of Operations and Financial Condition, Finan..
07/26 USANA HEALTH SCIENCES : Reports Record Second Quarter Financial Results
07/19 USANA HEALTH SCIENCES : @TeamUSANA Steps Onto The World Stage As More Than 70 At..
07/12 USANA HEALTH SCIENCES : Schedules Second Quarter Earnings Release and Conference..
06/16 USANA HEALTH SCIENCES : An Application for the Trademark "USANA" Has Been Filed ..
06/14 USANA : Takes Home Two Major Awards at the 2016 DSA Annual Meeting
06/02 USANA HEALTH SCIENCES : Receives Seal of Approval for Joint Health Supplement
05/19 USANA HEALTH SCIENCES' : China Subsidiary, BabyCare Ltd., Receives Approval for ..
More news
Sector news : Personal Products - NEC
07/28DJCOLGATE PALMOLIVE : Revenue Declines -- Update
07/28DJL'OREAL : Correction to L'Oréal earnings
07/28DJL'ORÉAL : Profit Sinks On Write-Downs, FX -- Update
07/28DJL'OREAL : L'Oré al Profit Sinks on Write-Downs, Currency Headwinds
07/28DJL'ORÉAL : Profit Sinks On Write-Downs, Currency Headwinds
More sector news : Personal Products - NEC
News from SeekingAlpha
07/27 USANA Health Sciences' (USNA) CEO Dave Wentz on Q2 2016 Results - Earnings Ca..
07/26 USANA Health Sciences beats by $0.02, beats on revenue
07/26 Zeek's Criminal Fraud Case Raises Prospects For More Herbalife Charges
07/25 Notable earnings after Tuesday?s close
07/18 INSIDERINSIGHTS.COM DAILY ROUND UP 7 : Xpo, dsu, dca, erc
Advertisement
Financials ($)
Sales 2016 1 026 M
EBIT 2016 149 M
Net income 2016 63,9 M
Debt 2016 145 M
Yield 2016 -
P/E ratio 2016 16,90
P/E ratio 2017 24,18
EV / Sales 2016 1,74x
EV / Sales 2017 1,61x
Capitalization 1 644 M
More Financials
Chart USANA HEALTH SCIENCES, INC
Duration : Period :
USANA Health Sciences, Inc Technical Analysis Chart | USNA | US90328M1071 | 4-Traders
Full-screen chart
Technical analysis trends USANA HEALTH SCIE...
Short TermMid-TermLong Term
TrendsBullishBullishNeutral
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 3
Average target price 156 $
Spread / Average Target 14%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
David A. Wentz Co-Chief Executive Officer
Kevin G. Guest Co-Chief Executive Officer
Myron W. Wentz Chairman
Jim Brown Chief Operating Officer
Paul A. Jones CFO, CAO & Chief Leadership Development Officer
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
USANA HEALTH SCIENCES,..7.49%1 644
PROCTER & GAMBLE CO7.78%227 828
UNILEVER2.74%139 324
UNILEVER PLC20.62%139 302
COLGATE-PALMOLIVE COMP..11.72%66 354
ESTEE LAUDER COMPANIES..5.50%34 302
More Results